Stock Events

Medpace 

€294.5
+€6.1+2.12% Friday 20:55

Statistiche

In rialzo oggi
295.7
In ribasso oggi
290
In rialzo da 52 settimane
-
In ribasso da 52 settimane
-
Volume
0
Volume medio
-
Cap. di mercato
9.51B
Rapporto P/E
28.74
Rendimento da dividendi
-
Dividendo
-

Prossimamente

Guadagni

21OctAtteso
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q3 2024
1.8
2.27
2.73
3.2
EPS attesi
2.770639
EPS effettivi
3.01

Le persone seguono anche

Questo elenco si basa sulle watchlist delle persone su Stock Events che seguono 01P.F. Non rappresenta una raccomandazione d'investimento.

Concorrenti

Questo elenco è un'analisi basata su recenti eventi di mercato. Non è una raccomandazione di investimento.

Info

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Show more...
CEO
Dr. August James Troendle M.D.
Dipendenti
5900
Paese
US
ISIN
US58506Q1094
WKN
000A2APTV

Quotazioni